| 引用本文:刘源源，祝婕.神仙解语丹加减联合舌三针治疗中风后失语症51例临床疗效观察[J].世界中医药,2016,(09):. |
|
| 神仙解语丹加减联合舌三针治疗中风后失语症51例临床疗效观察 |
| Clinical observation of Shengxian Jieyu Pill with Tongue Three Needle in Treatment of 51 Cases of Aphasia after Stroke |
| 投稿时间：2016-03-29 |
| DOI：10.3969/j.issn.1673-7202.2016.09.027 |
| 中文关键词: 中风 失语症 神仙解语丹 舌三针 |
| English Keywords:Stroke Aphasia Shengxian Jieyu Pill Tongue three needle |
| 基金项目:乌鲁木齐市卫生局课题基金(编号：201016) |
|
| 摘要点击次数: 1238 |
| 全文下载次数: 1428 |
| 中文摘要: |
| 目的：观察神仙解语丹加减联合舌三针治疗中风后失语症的临床疗效。方法：临床纳入102例中风后失语症患者，按随机数字表法分为2组各51例。2组均采用舒尔氏（Schuell）刺激法行言语康复训练，30 min/次，3次/周。其中51例患者采用舌三针治疗作为对照组，另51例在上述基础上加用神仙解语丹加减内服治疗作为观察组。疗程均为4周。采用中国康复研究中心失语症检查表（CRRCAE）评价言语功能；采用神经功能缺损程度评分量表（CSS）评价神经缺损伤功能，治疗前后各1次。结果：观察组失语症临床总有效率为96.08%，高于对照组的82.35%（χ2＝4.993，P<0.05）；治疗后2组患者CRRCAE检查表各因子评分均显著增高（P<0.01）；治疗后观察组CRRCAE检查表各因子评分均明显高于对照组（P<0.01）；治疗后2组患者CSS评分均显著低于治疗前（P<0.01），且观察组CSS评分低于对照组（P<0.01）。结论：神仙解语丹加减联合舌三针治疗中风后失语症患者，具有较好的临床效果，值得临床推广应用。 |
| English Summary: |
| To observe the clinical curative effect of Shengxian Jieyu Pill combined with Tongue three needle treatment of aphasia after stroke. Methods: Total 102 patients with aphasia after stroke were included, according to random number table method and were divided into two groups, with 51 cases in each group. Both two groups adopted ShuErShi line (Schuell) stimulus speech rehabilitation training, 30 min/time, 3 times per week. control group were treated with tongue three needle treatment, and the observation group were treated with Shengxian Jieyu Pill on the basis of the above treatment. Treatment of both groups lasted for 4 weeks. Chinese rehabilitation research center aphasia examination (CRRCAE) table was used to evaluate the speech function; the degree of nerve function defect score scale (CSS) to evaluate nerve damage function deficiency, the evaluation was performed both once before and after the treatment. Results: The aphasia clinical total effective rate of the observation group was 96.08%, higher than control group’s 82.35% (χ2=4.993, P<0.05）; The CRRCAE improved in both groups after treatment significantly (P<0.01）; factor’s scores on CRRCAE checklist of the observation group were significantly higher than control group (P<0.0）; CSS scores of the two groups were significantly lower after treatment (P<0.0）, and CSS score of the observation group was lower than the control group (P<0.0）. Conclusion: Shengxian Jieyu Pill combined with tongue three needle treatment has good clinical effect on patients with aphasia after stroke, which worthy of clinical use. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
